CLINICAL_TRIALS
research
· 2022-10-20
Clinical Trial Update: Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT) [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial update on reirradiation for diffuse intrinsic pontine glioma (DIPG) is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Brain Cancer | Phase 1, Phase 2 | Status: COMPLETED